These findings are confirmed by silencing Atg7 gene using small interfering RNA, which significantly reverses the therapeutic effect of KD on metabolic syndrome, which were manifested by aggravated insulin resistance and lipid accumulation in oleic acid-induced LO2 cells. Here, ATG7 is linked to metabolic syndrome.